OBJECTIVES: Benign gastro-oesophageal anastomotic strictures after oesophagectomy can occur in up to 42% of patients. Traditional management includes serial dilations. We report our initial experience with the use of a dual-anchor, lumen-apposing endoluminal stent for the management of recurrent anastomotic strictures after oesophagectomy.
INTRODUCTION
The prognosis for patients with oesophageal cancer is still unfavourable, and the 5-year survival rate rarely exceeds 35% [1] . Surgery, as part of a multimodality therapy, is considered the best curative approach in selected candidates [1] . Common complications after oesophagectomy include anastomotic leaks, which by themselves can result in anastomotic strictures or pure postoperative anastomotic strictures. Some oesophageal strictures such as neoplastic, post-surgical and radiation-induced strictures typically require multiple dilations to keep the lumen open [2] . Benign oesophagogastric anastomotic strictures are not a rare complication after oesophagectomy. The incidence of this complication depends on the type of oesophageal resection (transhiatal, Ivor-Lewis or McKeown), the location of the anastomosis (cervical or thoracic), type of anastomosis (stapled-circular or linear; hand-sewn; end-to-end; end-to-side) and the presence of conduit ischemia among other factors. Benign strictures of the gastro-oesophageal anastomosis occur in 10-31% of patients after transhiatal oesophagectomy and in up to 42% of patients in all types of esophagectomies [1] . Risk factors for anastomotic strictures are postoperative anastomotic leak; conduit ischemia; stapled circular rather than hand-sewn anastomosis; hand-sewn rather than mechanical linear stapled side-to-side; hand-sewn end-to-end rather than end-to-side oesophagogastric anastomosis and cardiac disease [1, 3] . In the majority of cases, blood supply to the gastric conduit is based on the right gastro-oepiploic artery. About 60% of the blood supply to the gastric conduit is supplied by this artery, whereas the proximal segment is supplied initially by collateral circulation between the right gastro-oepiploic artery, the left gastro-oepiploic artery and the dense submucosal and microvascular network. The oesophagogastric anastomosis is usually located in the most proximal part of the gastric conduit, which is also the area most prone to ischemia and stricture. Different approaches have been described for the treatment of anastomotic strictures. These include balloon dilation [2] , Maloney [4] and Savary-Gilliard rigid dilators [2, 4] , self-expanding metal stents (SEMSs) and plastic stents [5] , steroid and mitomycin C injections and electrocautery incisions. The majority of strictures respond well to dilations, with a median of 3 to 9 dilations to resolve dysphagia. Up to 39% of patients require more than three dilations to manage the anastomotic stricture [3] . Major complications occur in 0.4% of dilations for anastomotic stricture [3] . A small fraction of strictures are undilatable or recur after frequent multiple dilations. A refractory, recurrent stricture is defined as an anatomic restriction due to cicatricial luminal compromise or fibrosis that results in the clinical symptom of dysphagia in the absence of endoscopic evidence of inflammation. It occurs as the result of either an inability to successfully remediate the anatomic problem to a diameter of 14 mm over five sessions at 2-week intervals (refractory) or as a result of an inability to maintain a satisfactory luminal diameter for 2 weeks once the target diameter of 14 mm has been achieved (recurrent).
We report our initial experience with 'off label' use of a dualanchor, lumen-apposing stent (AXIOS, Boston Scientific, Marlborough, MA, USA) in the management of a short (< 1 cm) recurrent anastomotic stricture after oesophagectomy.
METHODS

Patients
The records of patients who had an AXIOS stent placed from January 2015 to July 2015 at the University of Minnesota Medical Center were analysed ( Table 1 ). The records of those who underwent placement of AXIOS stents for recurrent oesophagogastric or oesophagojejunal anastomotic strictures were included and reviewed. The diagnosis of refractory anastomotic stricture was made on the basis of clinical and endoscopic criteria. As part of our practice, prior to stent placement, all patients were discussed at our multidisciplinary complex oesophageal conference and a collective decision was made to treat the stricture with an AXIOS stent. This retrospective study was approved by our institutional review board. All patients gave informed consent before deployment of the dual-anchor stent.
Dual-anchor stent (AXIOS)
The AXIOS dual-anchor stent has an hourglass shape when fully deployed. Its delivery system is a through-the-scope, fully covered, SEMS (Fig. 1 ). This stent is composed of braided Nitinol that is fully covered with silicone, with wide bilateral anchor flanges. Fully expanded, the flange diameter is twice that of the saddle section; this design helps to maintain tissue layers in apposition and reduce the probability of stent migration. This stent is delivered through a 10.5F catheter. The delivery system attaches to a Luer-lock connector in the inlet port of the instrumentation channel. The handle permits the two-step release of each flange, which allows controlled stent placement and easy removal.
Procedure
Dual-anchor stent placement and dilation were done as outpatient procedures in the endoscopy suite or operating room with the use of intravenous sedation or general anaesthesia. A therapeutic adult gastroscope was used to localize and characterize the stricture (Fig. 2) . If the stricture was too narrow to allow passage of the endoscope to perform a complete examination, a pediatric endoscope was used to traverse it. A guidewire was advanced through the endoscope into the stomach and the endoscope was removed. The AXIOS delivery catheter was loaded into the therapeutic double-channel endoscope with the guidewire back-loaded into the delivery catheter. Under fluoroscopic and endoscopic guidance, the stent was advanced and deployed through the stricture. The stent was then dilated using through-the-scope dilating balloons (Fig. 3) . A chest radiograph was obtained in recovery room to assess the position of the stent and to follow it in case of migration (Fig. 4) 
Outcome parameters
The primary outcome parameters were technical and clinical success and safety. Technical success was defined as adequate dilation and patency of the anastomotic stricture after the use of a dual-anchor stent. Clinical success was defined as resolution of dysphagia without the need for further endoscopic or dilation procedures. Safety was defined by the frequency of the occurrence of major procedure-related adverse events, such as bleeding, perforation and stent migration. Bleeding was defined as any haemorrhagic event that required a revision endoscopic procedure, blood product transfusion or inpatient observation. Perforation was defined as pneumomediastinum on imaging studies in association with chest pain and an inflammatory response. Stent migration was defined as a stent position other than the stricture detected by radiological or endoscopic means.
RESULTS
Study population
During the study period, a total of 141 AXIOS stents were deployed at our institution, 132 of them as a bridge to drain transluminal collections and nine in the endoluminal position. Of the latter, four patients were identified as having benign refractory anastomotic strictures after oesophagectomy. All patients were men aged 60-64 years. The most commonly associated symptom was dysphagia. The initial diagnoses for which surgery was done were Barrett s oesophagus with high-grade dysplasia in one patient, localized oesophageal carcinoma in two patients and metastatic oesophagogastric gastrointestinal stromal tumour (GIST) in one patient. The anastomosis was located in the neck in two patients; one had an intrathoracic oesophagojejunal anastomosis and one an intrathoracic oesophagogastric anastomosis. All of these patients developed an anastomotic oesophagogastric or oesophagojejunal anastomotic stricture at a median of 17 weeks after surgery. The strictures were treated with serial oesophageal dilations without resolution of symptoms. One patient developed an enterobronchial fistula 2 cm distal to the anastomosis; one had a post-dilation haemorrhage requiring readmission and repeat endoscopy for clot removal. A dual-anchor stent was deployed to keep the stricture open. One stent had to be removed due to persistent severe thoracic pain three days after deployment. The stent was easily removed by rat tooth forceps.
Case 1
A 62-year-old man with Barrett's oesophagitis with high-grade dysplasia underwent a transhiatal oesophagectomy with gastric interposition and cervical oesophagogastric anastomosis at an outside institution that was complicated by a recurrent laryngeal nerve injury. Six years after the oesophagectomy, he developed regurgitation of undigested food and a 'choking' sensation. A barium ooesophagram showed 30% linear narrowing at the oesophagogastric anastomosis. He underwent multiple dilations at another institution before transferring to our care. After we performed upper endoscopy with biopsies to rule out recurrence, we found that the stricture was located 21 cm from the incisors and was 7 mm in diameter and <10 mm in length. We performed two dilations with a controlled radial expansion balloons (CRE TM, Boston Scientific, Marlborough, MA) to 10 and 14 mm . After symptom recurrence, we deployed a 15-Â 10-mm AXIOS stent. The stent was removed after 3 months and the anastomosis was found healthy with no residual stricture. The patient had recurrence of symptoms 7 weeks later and a new AXIOS 15 Â 10 stent was deployed. Repeat endoscopic examination at 3 months required stent repositioning due to angulation on the proximal limb. At 3 months, endoscopic examination showed a dilated anastomosis with a slightly angled stent, showing that the dual lumen stent was now too small. Once dysphagia recurred, a fully covered 14-mm oesophageal stent was placed and then 3 weeks later, upsized to a 19-mm stent. He remains asymptomatic.
Case 2
A 64-year-old man with a previous diagnosis of atrial flutter, arterial hypertension, anaemia and previous gastric bypass presented with dysphagia, mild regurgitation and weight loss. An upper endoscopic examination demonstrated a lower oesophageal circumferential adenocarcinoma (Siewert type 2). He underwent a distal oesophagectomy in our institution with a roux-en-Y intrathoracic oesophagojejunal end-to-side anastomosis with a circular stapler. His postoperative course was protracted due to colonic obstruction that required gastric remnant removal. He developed dysphagia 6 weeks after the initial surgery. Repeat endoscopy showed an anastomotic stricture 30 cm from the incisors. A total of five dilations with Savary-Gilliard dilators were performed. The last dilation was complicated by bleeding at the anastomotic stricture, which required hospital admission and repeat endoscopy to treat the bleeding site. The following endoscopic examination revealed a 5-mm inner diameter, 5-mm long stricture; a 10-Â 10-mm AXIOS stent was placed and dilated to 9 mm. After 2 weeks, the patient developed progressive dysphagia, odynophagia and regurgitation of undigested food. Six weeks after initial stent placement, repeat endoscopy showed occlusion of the AXIOS stent (food impaction) that could not be cleared.
The stent was then replaced with a 15-Â 10-mm AXIOS stent that was dilated to 15 mm. Repeat endoscopy 4 months later demonstrated partial distal migration into the jejunum; the stent was removed endoscopically and a new AXIOS 15-Â 10-mm stent was inserted and this time sutured in place using the overstitch endoscopic suturing device (Apollo Endosurgery, Austin, TX, USA) that inserted three independent sutures at the proximal flange to prevent migration into the dilated distal jejunal limb. An ooesophagram 3 months afterwards demonstrated no stent migration, obstruction or leak. He had disease recurrence and opted for hospice with the stent in place because it allowed him to eat.
Case 3
A 60-year-old man with type 2 diabetes mellitus and hypertension presented with dysphagia, regurgitation and weight loss. Upper endoscopy revealed adenocarcinoma at the gastro-oesophageal junction (Siewert 2). The patient had neoadjuvant chemotherapy without radiotherapy. A minimally invasive oesophagectomy was performed without complications and a cervical end-to-end, hand-sewn two-layer anastomosis was performed. He developed progressive dysphagia 7 weeks postoperatively; an anastomotic stricture was detected 23 cm from the incisors. The stricture had an inner diameter of 3 mm and was less than 10 mm in length. He first underwent dilation with Savary-Gilliard dilators and subsequently with a CRE balloon 3 weeks later. These procedures were unsuccessful for symptom control. Repeat endoscopy demonstrated a recurrent stricture that was dilated to 8 mm; a 15-Â 10-mm AXIOS stent was placed and then dilated to 12 mm. After almost 3 months, the stent was removed and the anastomosis was found to be patent and healthy appearing, with an inner diameter of 15 mm after stent removal. He underwent an ooesophagram 7 months after stent removal that showed the anastomosis at the junction of the proximal and middle third of the oesophagus with minimal narrowing and contrast passing easily through the anastomotic site with mild pooling above the anastomosis, which emptied readily with the assistance of gravity. The patient remains asymptomatic 13 months after stent removal.
Case 4
A 60-year-old man with rheumatoid arthritis and hypertension presented with right shoulder pain. A chest computed tomography revealed a 10-cm mediastinal mass that displaced the oesophagus. Biopsies were consistent with a gastrointestinal stromal tumour. He underwent neoadjuvant treatment with imatinib.
He underwent an open Ivor-Lewis oesophagectomy at an outside hospital. The intrathoracic anastomosis was performed with a linear stapler for posterior wall closure and interrupted sutures for the anterior wall. He developed dysphagia and cough almost 7 months after oesophagectomy. Endoscopy demonstrated stricture at 35 cm from the incisors with an inner diameter of 11 mm. A total of eight CRE balloon dilations were performed at an outside institution and dilated up to 18 mm. A tiny pinpoint gastropulmonary fistula was discovered 2 cm distal from the anastomosis. When dysphagia recurred, a 15-Â 10-mm AXIOS stent was placed to cover the anastomosis and the site of the previously seen fistula. Three days later, the patient developed severe chest pain related to stent placement, and the decision was made to remove the stent, resulting in resolution of the patient's chest discomfort. The small fistula was managed with the placement of a pharyngostomy tube to drain the fistulous track. Two weeks afterwards, repeat endoscopy with removal of the pharyngostomy tube showed a patent anastomosis and a closed fistulous tract after provocative manoeuvres with an on-table contrast ooesophagram. Follow-up endoscopy in 1 month showed a patent oesophagogastric anastomosis without evidence of stricture. He remains asymptomatic 6 months after removal of the AXIOS stent.
RESULTS
All patients had satisfactory deployment of the dual-anchor stent with adequate patency achieved. One case had minimal stent migration into a widely patent distal jejunum that was corrected by endoluminally suturing the proximal flange to the oesophagus. All patients had improvement of dysphagia immediately after stent placement, even the patient in whom the stent caused severe pain. One patient occluded his stent due to dietary non-compliance, which required an additional procedure 6 weeks after initial stent placement for deployment of a larger stent. Another patient experienced severe chest discomfort from pressure, which required early stent removal. We encountered one case of minimal stent migration due to a widely patent distal esophagojejunostomy, but we found no stent-related bleeding, perforations or delayed complications from stent erosion. In one patient who experienced persistent dysphagia despite stable oesophageal patency (>10 mm) after dual lumen stent therapy, we elected to continue dilating the stent to 19 mm.
DISCUSSION
Various studies that have analysed the performance of SEMSs and self-expanding plastic stents (SEPSs) in the treatment of refractory benign anastomotic strictures after oesophagectomy have reported mixed results [3, 6] . SEMSs are rarely used for benign oesophagogastric anastomotic strictures. The uncovered portions of partially covered SEMSs are associated with hyperplastic tissue reaction and incorporation of the stent mesh into the wall of the oesophagus, which makes removal difficult or impossible [3] . This hyperplastic tissue reaction may also result in recurrent dysphagia [6] . SEPSs are an alternative to SEMSs for benign strictures, because they are rarely associated with hyperplastic reaction around the stent [3, 6] . In a study by Barthel et al. [3] , placement of a SEPS significantly prolonged the interval between endoscopic interventions for stricture and reduced the number of interventions needed while the stent was in place, although SEPS placement did not result in stricture resolution or stabilization after removal. Stent migration is not an uncommon complication [3, 6] , especially for fully covered stents, with an incidence as high as 62% [7] . A recent report by Speer et al. in 23 patients who had 63 fully covered stents placed after oesophagectomy showed a 78% stent-related complication rate (62% migration, 11% clinically significant tissue overgrowth, 8% minor erosion-ulcers and 8% major erosion). Stent migration may be asymptomatic or cause dysphagia and chest pain. Additional complications include prolonged chest pain in 12-15% of patients; other rare complications reported are perforation and aortogastric fistula [8] .
To our knowledge, this study represents the first report of dual-anchor stents for the treatment of benign refractory anastomotic strictures after oesophagectomy. Dual-anchor stents are used for transluminal drainage of peripancreatic fluid collections and have proved to be an effective treatment modality in this clinical scenario [9, 10] . The dual-anchor configuration of this type of stent makes it more stable and less likely to migrate when one is treating short benign postoperative oesophageal strictures as opposed to the relatively high migration rate seen with SEMSs and SEPSs. In addition, the AXIOS stent is softer and exerts less radial force compared to traditional SEMSs, which intuitively makes it more appealing for endoluminal applications.
Our experience is small but represents the largest number of dual-anchor stents used for this unique population. We had to exchange one stent for a larger size secondary to food impaction due to dietary non-compliance, and one patient developed severe pressure-type symptoms after stent deployment and begged to have the stent removed, although his dysphagia symptoms were improved. A strict mechanical soft diet is enforced after stent placement to prevent stent occlusion. We are not aware of other delayed complications related to the use of dual-anchor stents in the oesophageal position from our patients or reported in the international literature. We also show that serial repeated rigid oesophageal dilations can lead to serious complications such as a small gastropulmonary fistula or bleeding. We have now converted to only using the larger 15-Â 10-mm stent for this purpose and believe that, as newer models with larger and longer common channels come to market, the application of endoluminal dual-anchor stents will broaden. Ideally, we believe the strictures should be serially dilated with dual-anchor stents, thereby allowing a larger patent anastomosis. Continued development of newer stents with customizable lengths and sizes would allow truly individualized care in this subset of patients.
The dual-anchor configuration makes the stent less prone to migration, although in our series, we noted at the time of scheduled endoscopy (not due to obstruction as the patient was still eating normally) that the stent had migrated slightly into a patulous jejunum (25%). We believe that a combination of dilation and a patulous jejunal limb made it more prone to migrate, requiring proximal endoluminal fixation.
At our multidisciplinary oesophageal centre, we created a flowchart to follow and assess all of our 'off label' stent patients in standardized fashion (Fig. 5) .
In conclusion, the use of fully covered self-expanding dual-anchor stents appears to be safe and valuable for the treatment of recurrent benign anastomotic strictures after oesophagectomy.
The migration rate seems lower than that reported for traditional self-expanding oesophageal stents. The use of these stents should be considered in patients with post-esophagectomy recurrent strictures that fail to respond to serial dilations. Although our limited experience is encouraging, we lack long-term results. We feel that dual-anchor stents should be considered for treatment of refractory anastomotic strictures; nevertheless, they still cannot be considered the gold standard or a definitive solution but should be viewed as a safe bridge to resolution of the stricture, repeat stent or further decision making related to more invasive procedures while allowing the patient to maintain oral intake and carry on living his or her life free from the symptoms of dysphagia.
